Resveratrol reduces steroidogenesis in rat ovarian theca-interstitial cells: The role of inhibition of Akt/ PKB signaling pathway

Endocrinology

Volumn 153, Issue 8, 2012, Pages 4019-4029

  Ortega, Israel ^a,c   Villanueva, Jesus A ^a   Wong, Donna H ^a   Cress, Amanda B ^a   Sokalska, Anna ^a,d   Stanley, Scott D ^b   Duleba, Antoni J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c INSTITUTO VALENCIANO DE INFERTILIDAD   (Spain)

^d POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANDROSTENEDIONE; ANDROSTERONE; CYTOCHROME P450 17; FARNESYL DIPHOSPHATE; GERANYLGERANYL PYROPHOSPHATE; MESSENGER RNA; NICOTINAMIDE; PROGESTERONE; PROTEIN KINASE B; RESVERATROL; SIRTINOL;

ANDROGEN SYNTHESIS; ANIMAL CELL; ARTICLE; CELL CULTURE; ENZYME INHIBITION; FEMALE; GENE EXPRESSION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; STEROIDOGENESIS; THECA CELL;

ANIMALS; BLOTTING, WESTERN; CELLS, CULTURED; FEMALE; MASS SPECTROMETRY; OVARY; RATS; RATS, SPRAGUE-DAWLEY; REAL-TIME POLYMERASE CHAIN REACTION; STEROIDS; STILBENES; THECA CELLS;

EID: 84864383673     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2012-1385     Document Type: Article

References (47)

1. Gelety TJ, Magoffin DA 1997 Ontogeny of steroidogenic enzyme gene expression in ovarian theca-interstitial cells in the rat: regulation by a paracrine theca-differentiating factor prior to achieving luteinizing hormone responsiveness. Biol Reprod 56:938-945 (Pubitemid 27150423)
2. Hall PF 1986 Cytochromes P-450 and the regulation of steroid synthesis. Steroids 48:131-196
3. Diamanti-Kandarakis E, Kouli CR, Bergiele AT, Filandra FA, Tsianateli TC, Spina GG, Zapanti ED, Bartzis MI 1999 A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile. J Clin Endocrinol Metab 84:4006-4011 (Pubitemid 30644187)
4. Asunción M, Calvo RM, San Millán JL, Sancho J, Avila S, Escobar- Morreale HF 2000 A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. J Clin Endocrinol Metab 85:2434-2438
5. Wood JR, Ho CK, Nelson-Degrave VL, McAllister JM, Strauss 3rd JF 2004 The molecular signature of polycystic ovary syndrome (PCOS) theca cells defined by gene expression profiling. J Reprod Immunol 63:51-60 (Pubitemid 38988254)
6. Nelson VL, Legro RS, Strauss 3rd JF, McAllister JM 1999 Augmented androgen production is a stable steroidogenic phenotype of propagated theca cells from polycystic ovaries. Mol Endocrinol 13: 946-957 (Pubitemid 30645312)
7. Nelson VL, Qin KN, Rosenfield RL, Wood JR, Penning TM, Legro RS, Strauss 3rd JF, McAllister JM 2001 The biochemical basis for increased testosterone production in theca cells propagated from patients with polycystic ovary syndrome. J Clin Endocrinol Metab 86:5925-5933 (Pubitemid 33152646)
8. Liu Y, Jiang H, He LY, Huang WJ, He XY, Xing FQ 2011 Abnormal expression of uncoupling protein-2 correlates with CYP11A1 expression in polycystic ovary syndrome. Reprod Fert Develop 23: 520-526
9. Wickenheisser JK, Nelson-Degrave VL, McAllister JM 2005 Dysregulation of cytochrome P450 17α-hydroxylase messenger ribonucleic acid stability in theca cells isolated from women with polycystic ovary syndrome. J Clin Endocrinol Metab 90:1720-1727 (Pubitemid 40464044)
10. Wood JR, Nelson VL, Ho C, Jansen E, Wang CY, Urbanek M, McAllister JM, Mosselman S, Strauss 3rd JF 2003 The molecular phenotype of polycystic ovary syndrome (PCOS) theca cells and new candidate PCOS genes defined by microarray analysis. J Biol Chem 278:26380-26390 (Pubitemid 36876777)
11. Wickenheisser JK, Quinn PG, Nelson VL, Legro RS, Strauss 3rd JF, McAllister JM 2000 Differential activity of the cytochrome P450 17α-hydroxylase and steroidogenic acute regulatory protein gene promoters in normal and polycystic ovary syndrome theca cells. J Clin Endocrinol Metab 85:2304-2311 (Pubitemid 32269260)
12. Nelson-Degrave VL, Wickenheisser JK, Hendricks KL, Asano T, Fujishiro M, Legro RS, Kimball SR, Strauss 3rd JF, McAllister JM 2005 Alterations in mitogen-activated protein kinase kinase and extracellular regulated kinase signaling in theca cells contribute to excessive androgen production in polycystic ovary syndrome. Mol Endocrinol 19:379-390 (Pubitemid 40223462)
13. Beshay VE, Havelock JC, Sirianni R, Ye P, Suzuki T, Rainey WE, Carr BR 2007 The mechanism for protein kinase C inhibition of androgen production and 17α-hydroxylase expression in a theca cell tumor model. J Clin Endocrinol Metab 92:4802-4809 (Pubitemid 350223463)
14. Scott E, Steward WP, Gescher AJ, Brown K 2012 Resveratrol in human cancer chemoprevention-choosing the 'right' dose. Mol Nutr Food Res 56:7-13
15. Wu Y, Jia LL, Zheng YN, Xu XG, Luo YJ, Wang B, Chen JZ, Gao XH, Chen HD, Matsui M, Li YH 5 Jan 2012 Resveratrate protects human skin from damage due to repetitive ultraviolet irradiation. J Eur Acad Dermat Venereol 10.1111/j.1468-3083.2011.04414.x
16. Magyar K, Halmosi R, Palfi A, Feher G, Czopf L, Fulop A, Battyany I, Sumegi B, Toth K, Szabados E 2012 Cardioprotection by resveratrol: a human clinical trial in patients with stable coronary artery disease. Clin Hemorheol Micro 50(3):179-187
17. Huang TC, Lu KT, Wo YY, Wu YJ, Yang YL 2011 Resveratrol protects rats from Aβ-induced neurotoxicity by the reduction of iNOS expression and lipid peroxidation. PloS one 6:e29102
18. Supornsilchai V, Svechnikov K, Seidlova-Wuttke D, Wuttke W, Söder O 2005 Phytoestrogen resveratrol suppresses steroidogenesis by rat adrenocortical cells by inhibiting cytochrome P450 c21-hydroxylase. Horm Res 64:280-286 (Pubitemid 41758647)
19. Svechnikov K, Spatafora C, Svechnikova I, Tringali C, Söder O 2009 Effects of resveratrol analogs on steroidogenesis and mitochondrial function in rat Leydig cells in vitro. J Appl Toxicol 29:673-680
20. Wong DH, Villanueva JA, Cress AB, Sokalska A, Ortega I, Duleba AJ 2011 Resveratrol inhibits the mevalonate pathway and potentiates the antiproliferative effects of simvastatin in rat theca-interstitial cells. Fertil Steril 96:1252-1258
21. Bass TM, Weinkove D, Houthoofd K, Gems D, Partridge L 2007 Effects of resveratrol on lifespan in Drosophila melanogaster and Caenorhabditis elegans. Mech Ageing Dev 128:546-552 (Pubitemid 47498522)
22. Gerhardt E, Gräber S, Szego EM, Moisoi N, Martins LM, Outeiro TF, Kermer P 2011 Idebenone and resveratrol extend lifespan and improve motor function of HtrA2 knockout mice. PLoS ONE 6:e28855
23. Mao Z, Hine C, Tian X, Van Meter M, Au M, Vaidya A, Seluanov A, Gorbunova V 2011 SIRT6 promotes DNA repair under stress by activating PARP1. Science 332:1443-1446
24. Qiang L, Lin HV, Kim-Muller JY, Welch CL, Gu W, Accili D 2011 Proatherogenic abnormalities of lipid metabolism in SirT1 transgenic mice are mediated through Creb deacetylation. Cell Metab 14:758-767
25. Magoffin DA, Erickson GF 1988 Purification of ovarian theca-interstitial cells by density gradient centrifugation. Endocrinology 122:2345-2347
26. Duleba AJ, Spaczynski RZ, Olive DL, Behrman HR 1997 Effects of insulin and insulin-like growth factors on proliferation of rat ovarian theca-interstitial cells. Biol Reprod 56:891-897 (Pubitemid 27150417)
27. Ortega I, Cress AB, Wong DH, Villanueva JA, Sokalska A, Moeller BC, Stanley SD, Duleba AJ 2011 Simvastatin reduces steroidogenesis by inhibiting Cyp17a1 gene expression in rat ovarian thecainterstitial cells. Biol Reprod 86:1-9
28. Rzepczynska IJ, Piotrowski PC, Wong DH, Cress AB, Villanueva J, Duleba AJ 2009 Role of isoprenylation in simvastatin-induced inhibition of ovarian theca-interstitial growth in the rat. Biol Reprod 81:850-855
29. Pizarro JG, Verdaguer E, Ancrenaz V, Junyent F, Sureda F, Pallàs M, Folch J, Camins A 2011 Resveratrol inhibits proliferation and promotes apoptosis of neuroblastoma cells: role of sirtuin 1. Neurochem Res 36:187-194
30. Wong DH, Villanueva JA, Cress AB, Sokalska A, Ortega I, Duleba AJ 2011 Resveratrol inhibits the mevalonate pathway and potentiates the antiproliferative effects of simvastatin in rat theca-interstitial cells. Fertil Steril 96:1252-1258
31. Fukuda S, Orisaka M, Tajima K, Hattori K, Kotsuji F 2009 Luteinizing hormone-induced Akt phosphorylation and androgen production are modulated by MAP Kinase in bovine theca cells. J Ovar Res 2:17
32. Basini G, Tringali C, Baioni L, Bussolati S, Spatafora C, Grasselli F 2010 Biological effects on granulosa cells of hydroxylated and methylated resveratrol analogues. Mol Nutr Food Res 54(Suppl 2):S236-S243
33. Kolesarova A, Capcarova M, Maruniakova N, Lukac N, Ciereszko RE, Sirotkin AV 2012 Resveratrol inhibits reproductive toxicity induced by deoxynivalenol. J Environ Sci Heal A 47:1329-1334
34. Morita Y, Wada-Hiraike O, Yano T, Shirane A, Hirano M, Hiraike H, Koyama S, Oishi H, Yoshino O, Miyamoto Y, Sone K, Oda K, Nakagawa S, Tsutsui K, Taketani Y 2012 Resveratrol promotes expression of SIRT1 and StAR in rat ovarian granulosa cells: an implicative role of SIRT1 in the ovary. Reprod Biol Endocrin 10: 14-23
35. Chemler JA, Yan Y, Koffas MA 2006 Biosynthesis of isoprenoids, polyunsaturated fatty acids and flavonoids in Saccharomyces cerevisiae. Microb Cell Fact 5:20-28
36. Inglese J, Koch WJ, Caron MG, Lefkowitz RJ 1992 Isoprenylation in regulation of signal transduction by G-protein-coupled receptor kinases. Nature 359:147-150
37. Sokalska A, Wong DH, Cress A, Piotrowski PC, Rzepczynska I, Villanueva J, Duleba AJ 2010 Simvastatin induces apoptosis and alters cytoskeleton in endometrial stromal cells. J Clin Endocrinol Metab 95:3453-3459
38. Trapp J, Jung M 2006 The role of NAD+ dependent histone deacetylases (sirtuins) in ageing. Curr Drug Targets 7:1553-1560 (Pubitemid 44718312)
39. Jin Q, Yan T, Ge X, Sun C, Shi X, Zhai Q 2007 Cytoplasm-localized SIRT1 enhances apoptosis. J Cell Physiol 213:88-97
40. Fernández AF, Fraga MF 2011 The effects of the dietary polyphenol resveratrol on human healthy aging and lifespan. Epigenetics 6:870-874
41. Knight CM, Gutierrez-Juarez R, Lam TK, Arrieta-Cruz I, Huang L, Schwartz G, Barzilai N, Rossetti L 2011 Mediobasal hypothalamic SIRT1 is essential for resveratrol's effects on insulin action in rats. Diabetes 60:2691-2700
42. Méndez E, Maeland M, Skålhegg BS, Planas JV 2003 Activation of the cAMP-dependent protein kinase signaling pathway by luteinizing hormone in trout theca layers. Mol Cell Endocrinol 205:11-20 (Pubitemid 37297347)
43. Tajima K, Yoshii K, Fukuda S, Orisaka M, Miyamoto K, Amsterdam A, Kotsuji F 2005 Luteinizing hormone-induced extracellularsignal regulated kinase activation differently modulates progesterone and androstenedione production in bovine theca cells. Endocrinology 146:2903-2910 (Pubitemid 41002797)
44. Song G, Ouyang G, Bao S 2005 The activation of Akt/PKB signaling pathway and cell survival. J Cell Mol Med 9:59-71
45. Walle T, Hsieh F, DeLegge MH, Oatis Jr JE, Walle UK 2004 High absorption but very low bioavailability of oral resveratrol in humans. Drug Metab Dispos 32:1377-1382 (Pubitemid 39564557)
46. Bruner-Tran KL, Osteen KG, Taylor HS, Sokalska A, Haines K, Duleba AJ 2011 Resveratrol inhibits development of experimental endometriosis in vivo and reduces endometrial stromal cell invasiveness in vitro. Biol Reprod 84:106-112
47. Patel KR, Brown VA, Jones DJ, Britton RG, Hemingway D, Miller AS, West KP, Booth TD, Perloff M, Crowell JA, Brenner DE, Steward WP, Gescher AJ, Brown K 2010 Clinical pharmacology of resveratrol and its metabolites in colorectal cancer patients. Cancer Res 70:7392-7399